V
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K274.5 KBVerve Therapeutics, Inc.Jul 25, 4:16 PM ET·0001193125-25-165462
- 8-K151.1 KBVerve Therapeutics, Inc.Jul 15, 6:16 AM ET·0001193125-25-159005
- 8-K1.3 MBVerve Therapeutics, Inc.Jun 17, 7:18 AM ET·0001193125-25-141748
- 8-K149.4 KBVerve Therapeutics, Inc.Jun 10, 4:17 PM ET·0001193125-25-138470
- 10-Q9.2 MBVerve Therapeutics, Inc.May 14, 7:30 AM ET·0000950170-25-070911
- 8-K330.0 KBVerve Therapeutics, Inc.May 14, 7:15 AM ET·0000950170-25-070905
- 8-K166.7 KBVerve Therapeutics, Inc.Apr 14, 7:15 AM ET·0001193125-25-079607
- 10-K14.4 MBVerve Therapeutics, Inc.Feb 27, 7:45 AM ET·0000950170-25-028376
- 8-K379.3 KBVerve Therapeutics, Inc.Feb 27, 7:15 AM ET·0000950170-25-028354
- SC 13G285.4 KBVerve Therapeutics, Inc.Nov 18, 5:23 PM ET·0000921895-24-002770
Insiders
10- ADELMAN BURT ADirector
- Alphabet Inc.10% Owner
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Ashe Andrew D.See Remarks
- Beam Therapeutics Inc.10% Owner
- Beaudoin MargaretVice President, Finance
- Bellinger AndrewChief Scientific Officer
- Biomatics Capital Partners, L.P.10% Owner
- Broad Institute, Inc.10% Owner
Tickers
No tickers on record
Addresses
business
201 BROOKLINE AVENUE SUITE 601
BOSTON, MA, 02215
mailing
201 BROOKLINE AVENUE SUITE 601
BOSTON, MA, 02215